Global Antidiabetic SGLT-2 Inhibitor Sales Market Report 2017

Global Antidiabetic SGLT-2 Inhibitor Sales Market Report 2017

1 Antidiabetic SGLT-2 Inhibitor Market Overview

1.1 Product Overview and Scope of Antidiabetic SGLT-2 Inhibitor

1.2 Classification of Antidiabetic SGLT-2 Inhibitor by Product Category

1.2.1 Global Antidiabetic SGLT-2 Inhibitor Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global Antidiabetic SGLT-2 Inhibitor Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Canagliflozin

1.2.4 Empagliflozin

1.2.5 Dapagliflozin

1.2.6 Other

1.3 Global Antidiabetic SGLT-2 Inhibitor Market by Application/End Users

1.3.1 Global Antidiabetic SGLT-2 Inhibitor Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Antidiabetic SGLT-2 Inhibitor Market by Region

1.4.1 Global Antidiabetic SGLT-2 Inhibitor Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.4.3 China Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.4.4 Europe Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.4.5 Japan Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.4.6 Southeast Asia Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.4.7 India Antidiabetic SGLT-2 Inhibitor Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Antidiabetic SGLT-2 Inhibitor (2012-2022)

1.5.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2022)

1.5.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2022)

2 Global Antidiabetic SGLT-2 Inhibitor Competition by Players/Suppliers, Type and Application

2.1 Global Antidiabetic SGLT-2 Inhibitor Market Competition by Players/Suppliers

2.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global Antidiabetic SGLT-2 Inhibitor (Volume and Value) by Type

2.2.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Type (2012-2017)

2.2.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Type (2012-2017)

2.3 Global Antidiabetic SGLT-2 Inhibitor (Volume and Value) by Region

2.3.1 Global Antidiabetic SGLT-2 Inhibitor Sales and Market Share by Region (2012-2017)

2.3.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Market Share by Region (2012-2017)

2.4 Global Antidiabetic SGLT-2 Inhibitor (Volume) by Application

3 United States Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

3.1 United States Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

3.1.1 United States Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

3.1.2 United States Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

3.1.3 United States Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

3.2 United States Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

3.3 United States Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

3.4 United States Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

4 China Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

4.1 China Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

4.1.1 China Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

4.1.2 China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

4.1.3 China Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

4.2 China Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

4.3 China Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

4.4 China Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

5 Europe Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

5.1 Europe Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

5.1.1 Europe Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

5.1.2 Europe Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

5.1.3 Europe Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

5.2 Europe Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

5.3 Europe Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

5.4 Europe Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

6 Japan Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

6.1 Japan Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

6.1.1 Japan Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

6.1.2 Japan Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

6.1.3 Japan Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

6.2 Japan Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

6.3 Japan Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

6.4 Japan Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

7 Southeast Asia Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

7.1 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

7.1.1 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

7.2 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

7.3 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

7.4 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

8 India Antidiabetic SGLT-2 Inhibitor (Volume, Value and Sales Price)

8.1 India Antidiabetic SGLT-2 Inhibitor Sales and Value (2012-2017)

8.1.1 India Antidiabetic SGLT-2 Inhibitor Sales and Growth Rate (2012-2017)

8.1.2 India Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate (2012-2017)

8.1.3 India Antidiabetic SGLT-2 Inhibitor Sales Price Trend (2012-2017)

8.2 India Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Players

8.3 India Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Type

8.4 India Antidiabetic SGLT-2 Inhibitor Sales Volume and Market Share by Application

9 Global Antidiabetic SGLT-2 Inhibitor Players/Suppliers Profiles and Sales Data

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Pfizer Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 AstraZeneca

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Johnson & Johnson

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 GlaxoSmithKline

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Merck & Co

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Merck & Co Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Eli Lilly

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Sanofi

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Sanofi Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Takeda Pharmaceuticals

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Novo Nordisk

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Servier Laboratories

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Antidiabetic SGLT-2 Inhibitor Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Boehringer Ingelheim

9.12 Bristol-Myers Squibb

10 Antidiabetic SGLT-2 Inhibitor Maufacturing Cost Analysis

10.1 Antidiabetic SGLT-2 Inhibitor Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

10.3 Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Antidiabetic SGLT-2 Inhibitor Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Antidiabetic SGLT-2 Inhibitor Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Antidiabetic SGLT-2 Inhibitor Market Forecast (2017-2022)

14.1 Global Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global Antidiabetic SGLT-2 Inhibitor Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Antidiabetic SGLT-2 Inhibitor Price and Trend Forecast (2017-2022)

14.2 Global Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global Antidiabetic SGLT-2 Inhibitor Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Antidiabetic SGLT-2 Inhibitor Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global Antidiabetic SGLT-2 Inhibitor Sales Forecast by Type (2017-2022)

14.3.2 Global Antidiabetic SGLT-2 Inhibitor Revenue Forecast by Type (2017-2022)

14.3.3 Global Antidiabetic SGLT-2 Inhibitor Price Forecast by Type (2017-2022)

14.4 Global Antidiabetic SGLT-2 Inhibitor Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

Figure Product Picture of Antidiabetic SGLT-2 Inhibitor

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume Comparison (K Pcs) by Type (2012-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (Product Category) in 2016

Figure Canagliflozin Product Picture

Figure Empagliflozin Product Picture

Figure Dapagliflozin Product Picture

Figure Other Product Picture

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Comparison (K Pcs) by Application (2012-2022)

Figure Global Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Other Examples

Table Key Downstream Customer in Other

Figure Global Antidiabetic SGLT-2 Inhibitor Market Size (Million USD) by Regions (2012-2022)

Figure United States Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate (2012-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Antidiabetic SGLT-2 Inhibitor Sales Share by Players/Suppliers

Figure 2017 Antidiabetic SGLT-2 Inhibitor Sales Share by Players/Suppliers

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Players

Table 2017 Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Players

Table Global Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Market Share by Type (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Share (K Pcs) by Type (2012-2017)

Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Type (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Type (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate by Type (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Market Share by Region (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Share by Region (2012-2017)

Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Region (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Growth Rate by Region in 2016

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Region (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Growth Rate by Region in 2016

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Antidiabetic SGLT-2 Inhibitor by Region (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share by Region in 2016

Table Global Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Market Share by Application (2012-2017)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of Antidiabetic SGLT-2 Inhibitor by Application (2012-2017)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market Share by Application (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure United States Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Figure China Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure China Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure China Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Figure India Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) and Growth Rate (2012-2017)

Figure India Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Antidiabetic SGLT-2 Inhibitor Sales Price (USD/Pcs) Trend (2012-2017)

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Players (2012-2017)

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players (2012-2017)

Figure India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Players in 2016

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Type (2012-2017)

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type (2012-2017)

Figure India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Type in 2016

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) by Application (2012-2017)

Table India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application (2012-2017)

Figure India Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share by Application in 2016

Table Pfizer Basic Information List

Table Pfizer Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Pfizer Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Pfizer Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure AstraZeneca Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Johnson & Johnson Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Merck & Co Basic Information List

Table Merck & Co Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merck & Co Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Merck & Co Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Merck & Co Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Eli Lilly Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Eli Lilly Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sanofi Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Sanofi Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Sanofi Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Takeda Pharmaceuticals Basic Information List

Table Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Takeda Pharmaceuticals Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Novo Nordisk Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Novo Nordisk Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Servier Laboratories Basic Information List

Table Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales Growth Rate (2012-2017)

Figure Servier Laboratories Antidiabetic SGLT-2 Inhibitor Sales Global Market Share (2012-2017

Figure Servier Laboratories Antidiabetic SGLT-2 Inhibitor Revenue Global Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Bristol-Myers Squibb Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antidiabetic SGLT-2 Inhibitor

Figure Manufacturing Process Analysis of Antidiabetic SGLT-2 Inhibitor

Figure Antidiabetic SGLT-2 Inhibitor Industrial Chain Analysis

Table Raw Materials Sources of Antidiabetic SGLT-2 Inhibitor Major Players in 2016

Table Major Buyers of Antidiabetic SGLT-2 Inhibitor

Table Distributors/Traders List

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Price (USD/Pcs) and Trend Forecast (2017-2022)

Table Global Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) Forecast by Regions (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share Forecast by Regions in 2022

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Regions (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Regions in 2022

Figure United States Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure China Antidiabetic SGLT-2 Inhibitor Revenue and Growth Rate Forecast (2017-2022)

Figure Europe Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Europe Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Japan Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Antidiabetic SGLT-2 Inhibitor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure India Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) Forecast by Type (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Volume Market Share Forecast by Type (2017-2022)

Table Global Antidiabetic SGLT-2 Inhibitor Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Revenue Market Share Forecast by Type (2017-2022)

Table Global Antidiabetic SGLT-2 Inhibitor Price (USD/Pcs) Forecast by Type (2017-2022)

Table Global Antidiabetic SGLT-2 Inhibitor Sales (K Pcs) Forecast by Application (2017-2022)

Figure Global Antidiabetic SGLT-2 Inhibitor Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources